Andrew Steer
Murdoch Children's Research Institute, VIC, Australia

Associate Professor Andrew Steer is a paediatric infectious diseases physician in the Department of General Medicine at the Royal Children’s Hospital Melbourne; Director of the Infection and Immunity Theme at the Murdoch Children’s Research Institute, Melbourne; group leader of the Group A Streptococcal Research Group at the Murdoch Children’s Research Institute, Melbourne; and principal research fellow at the Centre for International Child Health at the University of Melbourne. He is a founding committee member and current Chair of the International Alliance for the Control of Scabies. A/Prof Steer’s research interests are epidemiology and control of tropical childhood skin diseases; group A streptococcal clinical and molecular epidemiology; group A streptococcal vaccine research; rheumatic heart disease pathogenesis, epidemiology and control.
Presentations this author is a contributor to:
Strategic and scientific contributions of human challenge trials for Strep A vaccine development: facts versus fantasy (#162)
5:30 PM
Yara-Natalie Abo
Poster Session 1
Ripple effects following a surge of invasive Streptococcus pyogenes disease across Australian children’s hospitals (117275)
9:15 AM
Yara-Natalie Abo
Plenary 10 - Invasive Disease
CHIVAS-M1: No strain, no gain. Choosing an M1UK human challenge strain. (#164)
5:30 PM
Kristy I Azzopardi
Poster Session 1
Killing Strep A softly – towards standardised reagents for Streptococcus pyogenes immunoassays (#202)
5:30 PM
Kristy I Azzopardi
Poster Session 2
Cost of school screening for rheumatic heart disease and cost comparison of alternative strategies for confirmatory echocardiography in Uganda (118063)
2:27 PM
Joselyn Rwebembera
Concurrent 1b - Control Begins in the Community
Salivary signatures: mapping the dynamic human proteome in Strep A pharyngitis (118109)
11:44 AM
Anuk D Indraratna
Plenary 6 - Lessons From Niches of Stress, Vulnerability, and Resilience
Phase I Trial of a Peptide-based Vaccine to Prevent Group A Streptococcal Infection (118111)
9:15 AM
Michael F. Good
Plenary 5 - Interventions for Prevention
Historical Evidence for Streptococcus pyogenes as the Causative Agent of Acute Rheumatic Fever: A Structured Narrative Review (#159)
5:30 PM
Scott Wirth
Poster Session 1
Diagnostic accuracy of the 2023 world heart federation screening criteria for rheumatic heart disease in a high-risk population (#264)
5:30 PM
Joselyn Rwebembera
Poster Session 2
Putting public enemy #M1UK in the human challenge crosshairs (#168)
5:30 PM
Kimberly Davis
Poster Session 1
‘RHD in a dish’ -- Investigating the pathogenesis of Rheumatic Heart Disease using stem cell-derived heart valve organoids. (#246)
5:30 PM
Serene Yeow
Poster Session 2
Surveillance of Streptococus pyogenes induced pharyngitis in children from refugee and asylum seeker backgrounds via collaboration with a local health service (#269)
5:30 PM
Ciara Baker
Poster Session 2
Genomic epidemiology of S. pyogenes carriage and pharyngitis isolates from the STAMPS Australian paediatric surveillance study (#155)
5:30 PM
Jasmyn Voss
Poster Session 1
Towards a Human Whole Blood in Tube Assay to Measure Cellular Immunity to Streptococcus pyogenes Vaccine Antigens (#167)
5:30 PM
Natalie Caltabiano
Poster Session 1
Population pharmacokinetics of penicillin G: insights into increased clearance at low concentrations to guide development of improved long-acting formulations for syphilis and prevention of rheumatic fever (#135)
5:30 PM
Laurens Manning
Poster Session 1
The experience of streptococcal pharyngitis human challenge trial participants (#284)
5:30 PM
Jane Oliver
Poster Session 2
A novel approach to assess antigen specific Fc-mediated antibody functions induced by Streptococcus pyogenes pharyngitis (118113)
4:25 PM
Kaneka Chheng
Plenary 4 - Rapid Fire Session
Respiratory Group A Strep infections in stem cell models reveals divergent airway and alveolar epithelial cell responses (#243)
5:30 PM
Rhiannon Werder
Poster Session 2
A randomised, double-blinded, placebo-controlled human challenge trial to establish the lowest penicillin concentration to prevent Streptococcus pyogenes pharyngitis (CHIPS). (118511)
9:39 AM
Laurens Manning
Plenary 5 - Interventions for Prevention
Colonization with Streptococcus pyogenes elicits robust B cell responses against conserved vaccine antigens in paediatric tonsils (#191)
5:30 PM
Catherine Pitt
Poster Session 1
Comparative analysis of Strep A bacterial detection methods in an Australian paediatric urban pharyngitis surveillance study (#266)
5:30 PM
Anna Takahashi
Poster Session 2
Communication Strategies Used to Maximise Community-Based Participation in the Sore Throat Study in Perth and Melbourne (#283)
5:30 PM
Elizabeth Negus
Poster Session 2
Antibody Responses to Streptococcus pyogenes antigens in an Australian Longitudinal Paediatric Cohort Study (#186)
5:30 PM
Michael Morici
Poster Session 1
The Australian Strep A Vaccine Initiative (ASAVI) Urban Pharyngitis Surveillance Study (#126)
5:30 PM
John Hart
Poster Session 1
Evaluation of clinical decision rules for diagnosis of Streptococcus pyogenes pharyngitis in a tropical setting (119034)
12:20 PM
John Hart
Plenary 6 - Lessons From Niches of Stress, Vulnerability, and Resilience
A big picture view of progress towards a vaccine against Streptococcus pyogenes (123489)
1:45 PM
Andrew Steer
Plenary 3 - Big Picture Vaccine Development